Ding Q - Search Results

1

Association between VHL single nucleotide polymorphism (rs779805) and the susceptibility to prostate cancer in Chinese.

Chen J, Wu Y, Shao P, Cao Q, Qin C, Li P, Ding Q, Zhu J, Wang M, Zhang Z, Li J, Yin C. Chen J, et al. Among authors: ding q. DNA Cell Biol. 2012 May;31(5):790-6. doi: 10.1089/dna.2011.1408. Epub 2011 Nov 15. DNA Cell Biol. 2012. PMID: 22084938

2

A functional epidermal growth factor (EGF) polymorphism, EGF serum levels and renal cell carcinoma risk in a Chinese population.

Zhu J, Meng X, Yan F, Qin C, Wang M, Ding Q, Li P, Yang J, Ju X, Zhang Z, Wang S, Yin C. Zhu J, et al. Among authors: ding q. J Hum Genet. 2010 Apr;55(4):236-40. doi: 10.1038/jhg.2010.12. Epub 2010 Mar 5. J Hum Genet. 2010. PMID: 20203692

3

IL-16 polymorphism and risk of renal cell carcinoma: association in a Chinese population.

Zhu J, Qin C, Yan F, Wang M, Ding Q, Zhang Z, Yin C. Zhu J, et al. Among authors: ding q. Int J Urol. 2010 Aug;17(8):700-7. doi: 10.1111/j.1442-2042.2010.02559.x. Epub 2010 Jun 1. Int J Urol. 2010. PMID: 20529140

4

Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma.

Zhu J, Qin C, Wang M, Yan F, Ju X, Meng X, Ding Q, Li P, Yang J, Cao Q, Zhang Z, Yin C. Zhu J, et al. Among authors: ding q. Mol Carcinog. 2010 Sep;49(9):810-7. doi: 10.1002/mc.20656. Mol Carcinog. 2010. PMID: 20572163

5

Genetic polymorphisms in APE1 are associated with renal cell carcinoma risk in a Chinese population.

Cao Q, Qin C, Meng X, Ju X, Ding Q, Wang M, Zhu J, Wang W, Li P, Chen J, Zhang Z, Yin C. Cao Q, et al. Among authors: ding q. Mol Carcinog. 2011 Nov;50(11):863-70. doi: 10.1002/mc.20791. Epub 2011 May 2. Mol Carcinog. 2011. PMID: 21538578

6

Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population.

Shao P, Ding Q, Qin C, Wang M, Tang J, Zhu J, Chen J, Cao Q, Li J, Xu B, Zhang Z, Zhang W, Yin C. Shao P, et al. Among authors: ding q. Prostate. 2011 Jul;71(10):1122-30. doi: 10.1002/pros.21328. Epub 2011 Jan 12. Prostate. 2011. PMID: 21557277

7

The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.

Wang J, Ding Q, Shi Y, Cao Q, Qin C, Zhu J, Chen J, Yin C. Wang J, et al. Among authors: ding q. Mutagenesis. 2012 May;27(3):305-12. doi: 10.1093/mutage/ger078. Epub 2011 Nov 4. Mutagenesis. 2012. PMID: 22058059

8

Interleukin-10-819C>T polymorphism contributed to cancer risk: evidence from 29 studies.

Ding Q, Fan B, Fan Z, Ding L, Li F, Tu W, Jin X, Shi Y, Wang J. Ding Q, et al. Among authors: ding l. Cytokine. 2013 Jan;61(1):139-45. doi: 10.1016/j.cyto.2012.09.008. Epub 2012 Oct 6. Cytokine. 2013. PMID: 23046616

9

miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines.

Zhu C, Li J, Ding Q, Cheng G, Zhou H, Tao L, Cai H, Li P, Cao Q, Ju X, Meng X, Qin C, Hua L, Shao P, Yin C. Zhu C, et al. Among authors: ding q. Prostate. 2013 Jul;73(10):1082-9. doi: 10.1002/pros.22656. Epub 2013 Mar 4. Prostate. 2013. PMID: 23460133

10

The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls.

Ding Q, Shi Y, Fan B, Fan Z, Ding L, Li F, Tu W, Jin X, Wang J. Ding Q, et al. Among authors: ding l. PLoS One. 2013;8(2):e57246. doi: 10.1371/journal.pone.0057246. Epub 2013 Feb 27. PLoS One. 2013. PMID: 23460834 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,737 results

Search Page

Filters